You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pretreated locally advanced or metastatic cholangiocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

Recruiting
  • Cholangiocarcinoma
  • Ivosidenib Oral Tablet
  • Düsseldorf, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
May 17, 2023

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

Not yet recruiting
  • Locally Advanced Cholangiocarcinoma
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA Bundang Medical Center
    Jan 24, 2023

    Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

    Recruiting
    • Cholangiocarcinoma Non-resectable
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Aug 4, 2023

    Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

    Not yet recruiting
    • Cholangiocarcinoma
    • (no location specified)
    Dec 9, 2022

    Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)

    Terminated
    • Cholangiocarcinoma
    • Liver Neoplasms
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 8, 2022

    Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

    Not yet recruiting
    • Cholangiocarcinoma
    • (no location specified)
    Jan 16, 2023

    Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Jul 12, 2022

    Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin

    Recruiting
    • Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Nov 16, 2022

    Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

    Not yet recruiting
    • Locally Advanced Intrahepatic Cholangiocarcinoma
    • +4 more
    • Angiography
    • +8 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Sep 22, 2023

    Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      Allyson Welsch
    Jul 21, 2022

    Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

    Active, not recruiting
    • Cholangiocarcinoma
    • Shanghai, Shanghai, China
      Zhongshan Hospital Affiliated to Fudan University
    Oct 3, 2022

    Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

    Recruiting
    • Locally Advanced Intrahepatic Cholangiocarcinoma
    • +5 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)

    Not yet recruiting
    • Advanced Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Sep 30, 2022

    Cholangiocarcinoma, Intrahepatic Trial in Toronto (Liver Transplantation)

    Enrolling by invitation
    • Cholangiocarcinoma, Intrahepatic
    • Liver Transplantation
    • Toronto, Ontario, Canada
      University Health Network
    Apr 8, 2022

    Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

    Not yet recruiting
    • Bile Duct Cancer
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 23, 2023

    Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

    Not yet recruiting
    • Recurrent Vulvar Cancer
    • +3 more
    • (no location specified)
    Jun 12, 2023

    Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

    Not yet recruiting
    • Metastatic Hepatocellular Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 24, 2023

    Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • FOLFIRINOX treatment
    • (no location specified)
    Aug 9, 2023

    Solid Tumors Trial (IBR854 Cell Injection)

    Not yet recruiting
    • Solid Tumors
    • IBR854 Cell Injection
    • (no location specified)
    Aug 14, 2023

    HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

    Recruiting
    • HER2 Gene Mutation
    • Injection of IAH0968+Gemcitabine+Cisplatin
    • Gemcitabine+Cisplatin
    • Shanghai, China
      Fudan University Affiliated Zhongshan Hospital
    Aug 7, 2023

    Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

    Recruiting
    • Differentiated Thyroid Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 9, 2023

    Cholangiocarcinoma,Adult Trial (3D185)

    Not yet recruiting
    • Cholangiocarcinoma,Adult
    • (no location specified)
    Sep 2, 2021

    Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 7, 2023